You are here

Merck

Merck’s Keytruda gets FDA priority review for high-risk NMIBC

Pharmaceutical Business Review

Mon, 12/2/19 - 10:46 am

priority review

Having gobbled up Celgene, the Bristol-Myers CEO ducks questions about his key rival

Stat

Fri, 11/22/19 - 10:00 am

Bristol-Myers Squibb

Giovanni Caforio

Merck's Keytruda lung cancer sales may face new pressure, but investors shouldn't sweat it: analyst

Fierce Pharma

Wed, 11/20/19 - 10:36 pm

non-small cell lung cancer

AZ, Merck and Novartis top Big Pharma's Q3 growth charts. Teva and Pfizer? Not so much

Fierce Pharma

Tue, 11/19/19 - 11:38 pm

Merck and Bayer's heart drug meets main goal of late-stage study

Yahoo/Reuters

Mon, 11/18/19 - 10:00 am

AstraZeneca, Merck win red carpet treatment at the FDA as a 3-time loser seeks speedy OK for rare tumors

Endpoints

Thu, 11/14/19 - 10:21 am

Merck buys Calporta for preclinical neurodegeneration assets

Fierce Biotech

Wed, 11/13/19 - 10:07 am

Calporta Therapeutics

neurodegenerative disease

Merck to slash more than 100 R&D jobs from French site: report

Fierce Biotech

Wed, 11/13/19 - 10:05 am

The Ebola Vaccine Is Now Officially Here With Approval In Europe

Forbes

Mon, 11/11/19 - 07:53 pm

Regeneron defends bid to challenge Merck in lung cancer

Biopharma Dive

Tue, 11/5/19 - 11:45 pm

immuno-oncology

Should Merck Investors Worry About Bristol Myers' Lung Cancer Drug Results?

Motley Fool

Mon, 11/4/19 - 10:23 am

Bristol-Myers Squibb

Biopharma Q3: Pfizer, Merck, Amgen, Incyte and J&J

BioSpace

Sat, 11/2/19 - 07:55 pm

Merck again borrows Gardasil supplies from CDC

Biopharma Dive

Thu, 10/31/19 - 11:58 pm

Bristol-Myers warns I-O blockbuster Opdivo will be 'under pressure' in 2020

Fierce Pharma

Thu, 10/31/19 - 11:52 pm

Bristol-Myers Squibb

Merck CFO: we’re not only about Keytruda

PM Live

Wed, 10/30/19 - 11:16 pm

Merck loses bid to revive $2.54 billion patent verdict against Gilead

Yahoo/Reuters

Wed, 10/30/19 - 10:18 am

Gilead Sciences

Merck beats estimates as Keytruda sales top $3 billion for first time

Yahoo/Reuters

Tue, 10/29/19 - 09:50 am

The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings

Yahoo/Benzinga

Sun, 10/27/19 - 10:55 pm

Adamis Pharmaceuticals

Redhill Biopharma

Amag Pharmaceuticals

Agile Therapeutics

Agios Pharmaceuticals

Mirati Therapeutics

Sutro BioPharma

Bristol-Myers Squibb

Oyster Point Pharma

Can Merck (MRK) Keep the Earnings Beat Streak Alive in Q3?

Yahoo/Zacks.com

Sat, 10/26/19 - 02:21 pm

CHMP backs world’s first Ebola vaccine from Merck, NewLink

Pharmaforum

Mon, 10/21/19 - 10:13 am

NewLink Genetics

Pages